Around the world, 235 million people have asthma and 64 million have chronic obstructive pulmonary disease (COPD), as per the World Health Organization (WHO). The major causes of these highly morbid diseases are air pollution and exposure to cigarette smoke, chemicals, and dust. Additionally, every year, more children are suffering from these diseases than ever, which has led governments to take initiatives to reduce air pollution and discourage people against tobacco smoking.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/nebulizer-market-r...

The rising prevalence and mortality rate of chronic respiratory diseases will be the key factor driving the nebulizer market at a CAGR of 7.4% between 2020 and 2030 (forecast period). P&S Intelligence expects that at this rate, the market will grow from $765.1 million in 2019 to $1,698.1 million by 2030. A nebulizer is a medical device that covers drugs in their liquid form to an aerosol of fine droplets, so they can be delivered directly to the lungs, via a mouthpiece or mask.

Make an Enquiry Before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=nebulizer...

The nebulizer market is divided on the basis of product type into ultrasonic, pneumatic, and mesh. Among these, the pneumatic category dominated the industry in 2019, as such nebulizers do not have medication limitations and they can break the drug down into a range of particle sizes. Moreover, both portable and tabletop variants of pneumatic nebulizers are available, which makes them popular among the elderly. In the coming years, the mesh division is projected to witness the highest CAGR due to the technological advancements taking place in these devices.

In the years to come, the fastest rise in the sale of nebulizers is projected to be witnessed in Asia-Pacific (APAC). As per the WHO, “>90% of COPD deaths occur in low-income and middle-income countries.”. This reflects a vast unmet need for essential medical devices in the region, which is why the government in regional countries is taking efforts to increase their availability. India and China are home to a huge number of smokers, and they also account for an extremely poor air quality, both of which contribute to the high respiratory disease incidence here.

Hence, as more people fall prey to respiratory diseases, such as asthma and COPD, the demand for nebulizers will increase.